Evidence map›Paper›PMID 31517150›Full record

ArticleKidney international reports2019

Taeko Hashimoto, Yutaka Harita, Keiichi Takizawa, Seiya Urae, Kiyonobu Ishizuka, Kenichiro Miura, Shigeru Horita, Daisuke Ogino, Gen Tamiya, Hideki Ishida and 3 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nucleoporin-associated steroid-resistant nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  5. Advances in the understanding of nuclear pore complexes in human diseases.Journal of cancer research and clinical oncology · 2024
    Review
  6. Article
  7. Steroid-Resistant Nephrotic Syndrome Caused byJournal of clinical medicine · 2023
    Article
  8. A rare cause of steroid-resistant nephrotic syndrome - a case report.Central-European journal of immunology · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Taeko HashimotoDepartment of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.
Yutaka HaritaDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Keiichi TakizawaDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Seiya UraeDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kiyonobu IshizukaDepartment of Pediatric Nephrology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Kenichiro MiuraDepartment of Pediatric Nephrology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Shigeru HoritaDepartment of Pediatric Nephrology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Daisuke OginoDepartment of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.
Gen TamiyaTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Hideki IshidaDepartment of Urology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Tetsuo MitsuiDepartment of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.
Kiyoshi HayasakaDepartment of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.
Motoshi HattoriDepartment of Pediatric Nephrology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Tokyo Women's Medical University · JPYamagata University · JPThe University of Tokyo · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMutations in genes encoding nucleoporins (NUPs; components of nuclear pore complexes [NPCs]), such as

methodsThe expression of NUP93 in normal control kidney and in a patient with FSGS carrying

resultsImmunofluorescence analysis detected NUP93 expression in nuclei of all glomerular and tubulointerstitial cells in human kidneys. Whole-exome sequencing identified a compound heterozygous

conclusionNUP93 is expressed in the nuclei of all the cell types of the human kidney. Altered NUP93 expression in glomerular cells as well as extraglomerular cells by

Indexed as

focal segmental glomerulosclerosisnuclear pore complexnucleoporinNUP93steroid-resistant nephrotic syndrome

Identifiers

PMID31517150
PMCPMC6732778
OpenAlexW2947535515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.